Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers
- Lawrence R. Dearth
- , Hua Qian
- , Ting Wang
- , Timothy E. Baroni
- , Jue Zeng
- , Stephanie W. Chen
- , Sun Young Yi
- , Rainer K. Brachmann
Research output: Contribution to journal › Article › peer-review
118
Scopus
citations